March Issue of AABB News Focuses on Future of Antibody Therapies

The future of antibody therapies is the focus of the March issue of AABB News. This month’s first feature article examines the past, present and future of COVID-19 convalescent plasma (CCP) as a viable treatment. The second feature highlights AABB’s PLasma Antibody Network (PLAN), which was established at the height of the pandemic to advance the development of antibody therapies and strengthen the nation’s preparedness and response activities.  

A third feature highlights a newly funded initiative to develop a field-deployable, shelf-stable whole blood equivalent that can be used to resuscitate trauma patients when donated blood products are not available. In addition, the March issue includes a new wellness column, “Be Well,” which will cover stress management, burnout and other pertinent wellness topics.